Synaptic Stabilizers represent a promising therapeutic approach for neurodegenerative diseases aimed at preserving synaptic structure and function. This page provides comprehensive information about synaptic stabilization mechanisms, therapeutic strategies, and current research progress. [@selkoe2002]
Overview
Synaptic loss is a hallmark of neurodegenerative diseases and correlates strongly with cognitive decline. Synaptic stabilizers aim to prevent or reverse synaptic dysfunction by targeting proteins and pathways critical for synaptic structure, vesicle cycling, and neuronal connectivity. [@chen2023]
Mechanism of Action
Synaptic stabilizers employ multiple strategies to preserve synaptic function:
Synaptic Stabilizers represent a promising therapeutic approach for neurodegenerative diseases aimed at preserving synaptic structure and function. This page provides comprehensive information about synaptic stabilization mechanisms, therapeutic strategies, and current research progress. [@selkoe2002]
Overview
Synaptic loss is a hallmark of neurodegenerative diseases and correlates strongly with cognitive decline. Synaptic stabilizers aim to prevent or reverse synaptic dysfunction by targeting proteins and pathways critical for synaptic structure, vesicle cycling, and neuronal connectivity. [@chen2023]
Mechanism of Action
Synaptic stabilizers employ multiple strategies to preserve synaptic function:
1. Presynaptic Terminal Stabilization
Synaptophysin Modulation: Enhancing synaptophysin expression to maintain vesicle pools
Synapsin Regulation: Protecting synapsin from pathological modifications
Mitochondrial Support: Ensuring adequate energy supply for synaptic activity
2. Postsynaptic Density Protection
[NMDA Receptor](/entities/nmda-receptor) Modulation: Subtle modulation of NMDA receptor activity to prevent excitotoxicity while maintaining synaptic plasticity
The study of Synaptic Stabilizers has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
Selkoe DJ, Alzheimer's disease is a synaptic failure (2002)
Hung CO, Coleman MP, Protecting Synapses: An Emerging Treatment Strategy for Neurodegenerative Diseases (2016)
Liu J, et al, Synaptic dysfunction and regeneration in neurodegenerative diseases (2022)
Spires-Jones TL, Hyman BT, The intersection of amyloid beta and tau at synapses in Alzheimer's disease (2014)
Blennow K, et al, Synaptic pathology in Alzheimer's disease: beyond the cholinergic hypothesis (2000)
Dong Y, et al, Synaptic dysfunction in Alzheimer's disease: mechanisms and therapeutic strategies (2022)
Marsh J, et al, Synaptic stabilization as a therapeutic target in neurodegenerative disease (2021)
Chen X, et al, Small molecule synaptic stabilizers for neurodegenerative diseases (2023)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate